Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.28 USD | +0.10% | -3.68% | -27.78% |
05/06 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
15/05 | Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023. | CI |
Evolution of the average Target Price on OptimizeRx Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering OptimizeRx Corporation
JMP Securities | |
RBC Capital Markets | |
Barclays | |
Roth MKM | |
Lake Street | |
Stifel Nicolaus | |
B. Riley | |
Piper Sandler | |
SVB Securities LLC | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- OPRX Stock
- Consensus OptimizeRx Corporation